Get 40% Off
🔎 See NVDA's full ProTips for an instant risks or rewardsClaim 40% OFF

ACADIA Pharmaceuticals Inc (ACAD)

NASDAQ
Currency in USD
Disclaimer
24.85
-0.26(-1.04%)
Closed
After Hours
24.98+0.13(+0.52%)
Earnings results expected in 6 days
Day's Range
24.6025.10
52 wk Range
17.7133.99
Prev. Close
25.11
Open
24.73
Day's Range
24.6-25.1
52 wk Range
17.71-33.99
Volume
984,299
Average Vol. (3m)
1,785,093
1-Year Change
28.29%
Shares Outstanding
164,180,377
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
34.25
Upside +37.83%

People Also Watch

103.55
TOL
+1.34%
787.57
SMCI
-1.96%
276.09
ETN
-0.52%
31.23
KDP
+0.84%
How do you feel today about ACAD?
Vote to see community's results!
or

ACADIA Pharmaceuticals Inc Company Profile

Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. The Company’s portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address significant unmet needs in CNS disorders and rare diseases. The Company’s pipeline includes NUPLAZID, Trofinetide, ACP-204 and Antisense Oligonucleotide (ASO) Programs. Its NUPLAZID is a treatment for Parkinson’s Disease Psychosis. Trofinetide is a treatment for Rett Syndrome. Trofinetide is a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome by reducing neuroinflammation and supporting synaptic function. Its ACP-204 is a treatment for Alzheimer’s Disease Psychosis.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.